<div class="medium-8 columns">
    <h3 class="feed__title feed__title--display">
        <a href="/news/bristol-myers-johnson-milvexian-phase-3-blood-thinner/644007/">
            Bristol Myers, J&amp;J plan tests of new blood thinner in nearly 50,000 patients
        </a>
    </h3>

        <p class="feed__description">The Phase 3 program for their medicine, milvexian, will be among the largest in drug development and almost twice the size of what Bayer has planned for a competing treatment.</p>
            <span class="secondary-label">By Kristin Jensen &#8226;</span>
<span class="secondary-label">March 2, 2023</span>
</div>